The University of Chicago Header Logo

Connection

Mark Korpics to Cetuximab

Back to Details
This is a "connection" page, showing publications Mark Korpics has written about Cetuximab.
Mark Korpics
Connection Strength
0.194
Cetuximab
  1. Decreased overall survival in patients with locally advanced head and neck cancer receiving definitive radiotherapy and concurrent cetuximab: National Cancer Database analysis. Head Neck. 2022 07; 44(7):1528-1544.
    View in: PubMed
    Score: 0.194
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.